Drug
Siplizumab
Siplizumab: highest development phase Phase 2, developed by ITB-Med LLC. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- ITB-Med LLC
Trials
| Drug | Phase | Indication |
|---|---|---|
| Siplizumab NCT07508787 | Phase 2 | Renal Transplant Failure and Rejection |
Latest
No recent events.
Follow Siplizumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.